Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Earnings Preview Synchronoss Technologies Analyst Projections and Stock Progress

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
CRWD stock news
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Earnings Preview: Synchronoss Technologies

Synchronoss Technologies (NASDAQ: SNCR) is set to unveil its latest quarterly earnings report on March 12, 2024. Here are some key points for investors to keep in mind ahead of the announcement:

Analyst Projections: Analysts are forecasting that Synchronoss Technologies will post an earnings per share (EPS) of $-0.10 for this quarter.

Guidance Importance: In addition to surpassing earnings expectations, investors will be eager to see positive guidance for future growth as it can have a significant impact on stock prices.

Past Results: In the previous quarter, the company exceeded EPS estimates by $0.45, resulting in a 16.28% decrease in share price the next day. Here is a summary of past performance and the resulting price changes:

Quarter EPS Estimate EPS Actual Price Change %
Q3 2023 $0 $0.45 -16.0%
Q2 2023 $-0.27 $-0.27 7.00%
Q1 2023 $-0.18 $-0.72 -1.0%
Q4 2022 $0.54 $-0.72 -19.0%

Stock Progress: As of March 8, Synchronoss Technologies shares were trading at $10.84, demonstrating a positive trend with a 34.5% increase over the past 52 weeks.

For more comprehensive details regarding Synchronoss Technologies’ earnings history and performance, you can explore their earnings calendar on MarketBeat.

SNCR Stock Shows Strong Performance, Trading Near 52-Week High and Above Moving Average

On March 11, 2024, SNCR stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. The stock opened at $11.19, which was $0.35 higher than its previous close, indicating positive momentum right from the start of the trading day.

Throughout the day, SNCR shares saw a significant increase in price, rising by $1.00 since the market last closed. This represented a 9.18% increase in the stock price, showing strong bullish movement and investor interest in the company.

This price momentum can be attributed to various factors such as positive news, strong financial performance, or market optimism about the company’s future prospects. Investors may have been reacting positively to recent developments or earnings reports, driving up the stock price and pushing it towards the top of its 52-week range.

For investors following technical analysis, the fact that SNCR is trading above its 200-day simple moving average could signal further potential upside in the stock price. This moving average is often used by traders to identify trends and potential buying opportunities, suggesting that SNCR may continue to see positive price movement in the near term.

SNCR Stock Performance Analysis: Revenue Decline Offset by Net Income and EPS Growth

On March 11, 2024, investors closely watched the performance of SNCR stock following the release of the latest financial data. According to information from CNN Money, SNCR reported a total revenue of $252.63 million over the past year, with a significant decrease of 9.97% compared to the previous year. In the most recent quarter, the total revenue was $55.65 million, showing a decrease of 6.81% since the last quarter.

Despite the decline in total revenue, there was some positive news for SNCR as the net income showed improvement. The net income for the past year was reported at -$7.92 million, which represented a 65.5% increase compared to the previous year. In the last quarter, the net income was -$2.70 million, showing a significant improvement of 68.29% since the last quarter.

Additionally, the earnings per share (EPS) for SNCR also showed positive growth. The EPS for the past year was reported at -$1.82, indicating a 77.57% increase compared to the previous year. In the last quarter, the EPS was -$0.53, showing a 53.5% increase since the last quarter.

Overall, the financial data for SNCR on March 11, 2024, showed a mixed performance. While there was a decline in total revenue, the company managed to improve its net income and EPS. Investors will continue to monitor SNCR stock closely to see how the company performs in the coming quarters and whether it can sustain its positive growth trends.

Tags: SNCR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Anticipating Flotek Industries Quarterly Financial Results A Look at Past Performance and Market Expectations

Caesars Sportsbook Launches Mobile Wagering in North Carolina

Entertainment Trading online

Lions Gate Entertainment Corp Announces Merger with Screaming Eagle Acquisition Corp Creating Lionsgate Studios Corp

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com